Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.20 EUR | +0.82% |
|
+4.10% | +7.73% |
May. 05 | Gimv: investment in Ambulantis in Germany | CF |
May. 05 | Gimv to Buy Stake in German Outpatient Care Services Operator Ambulantis | MT |
Capitalization | 1.54B 1.73B 1.44B 1.3B 2.41B 148B 2.7B 16.82B 6.55B 66.96B 6.48B 6.35B 252B | P/E ratio 2023 * |
-
| P/E ratio 2024 | - |
---|---|---|---|---|---|
Enterprise value | 1.54B 1.73B 1.44B 1.3B 2.41B 148B 2.7B 16.82B 6.55B 66.96B 6.48B 6.35B 252B | EV / Sales 2023 |
-
| EV / Sales 2024 | - |
Free-Float |
58.13% | Yield 2023 |
5.84% | Yield 2024 | 5.84% |
More valuation ratios
* Estimated data
More news
More press releases
More news
1 day | +0.82% | ||
1 week | +3.47% | ||
Current month | +8.95% | ||
1 month | +12.65% | ||
3 months | +15.66% | ||
6 months | +14.13% | ||
Current year | +7.73% |
1 week | 41.3 | ![]() | 43.35 |
1 month | 38.25 | ![]() | 43.35 |
Current year | 34.5 | ![]() | 43.35 |
1 year | 34.5 | ![]() | 47.1 |
3 years | 34.5 | ![]() | 56.3 |
5 years | 34.5 | ![]() | 58 |
10 years | 34.5 | ![]() | 59.4 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 2007-12-31 | |
Director of Finance/CFO | 56 | 2007-08-31 | |
Johan Creemers
CTO | Chief Tech/Sci/R&D Officer | - | 2021-11-30 |
Director | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 2007-12-31 | |
Luc Missorten
BRD | Director/Board Member | 70 | 2014-06-24 |
Manon Janssen
BRD | Director/Board Member | 64 | 2016-12-31 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.82% | +3.47% | -5.57% | -20.44% | 1.72B | ||
-1.13% | +7.79% | +16.50% | +36.11% | 115B | ||
-2.63% | +8.11% | +22.65% | +143.63% | 115B | ||
-4.06% | +4.08% | +16.40% | +146.17% | 38.41B | ||
-0.54% | +2.84% | +3.27% | +33.36% | 16.99B | ||
-0.11% | +17.65% | +11.11% | +24.77% | 16.98B | ||
+0.18% | +4.26% | +1.98% | +12.92% | 14.92B | ||
-3.30% | +6.80% | +4.32% | +73.58% | 12.5B | ||
+0.77% | +8.41% | -9.17% | -11.60% | 11.57B | ||
+2.92% | +6.16% | +27.86% | +165.66% | 11.44B | ||
Average | -0.71% | +7.76% | +8.93% | +60.42% | 35.42B | |
Weighted average by Cap. | -1.68% | +9.34% | +15.97% | +84.96% |
2023 | 2024 | |
---|---|---|
Net sales | -12K -13.43K -11.22K -10.09K -18.74K -1.15M -20.96K -131K -50.91K -520K -50.36K -49.31K -1.95M | 292M 327M 273M 246M 456M 27.9B 510M 3.18B 1.24B 12.66B 1.23B 1.2B 47.56B |
Net income | -59.47M -66.54M -55.59M -50.01M -92.88M -5.68B -104M -648M -252M -2.58B -250M -244M -9.69B | 217M 243M 203M 183M 339M 20.75B 379M 2.36B 921M 9.41B 911M 892M 35.37B |
Net Debt | - | - |
More financial data
* Estimated data
Employees
93
Calendar
May. 22
- Q4 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-05-15 | 43.20 € | +0.82% | 24,244 |
25-05-14 | 42.85 € | -0.35% | 19,588 |
25-05-13 | 43.00 € | +2.63% | 43,791 |
25-05-12 | 41.90 € | +1.09% | 31,722 |
25-05-09 | 41.45 € | -0.12% | 13,641 |
Real-time Euronext Bruxelles, May 15, 2025 at 11:35 am EDT
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
3
Last Close Price
43.20EUR
Average target price
50.63EUR
Spread / Average Target
+17.21%
Annual profits - Rate of surprise
- Stock Market
- Equities
- GIMB Stock
Select your edition
All financial news and data tailored to specific country editions